KAMAL SHAH
-
Pharma's future bright but challenges persist in Gujarat
The Food and Drug Control Administration (FDCA) Gujarat issued at least 1,640 fresh licences to allopathic drug makers in the past three years i.e. 490 in 2020, 559 in 2021, and 551 in 2022. Estimates by industry players indicate this has drawn investments worth at least Rs 10,000 crore into the pharma sector of Gujarat.
Advertisement
Advertisement